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Abstract	 S Afr Fam Pract 2011;53(1):71-76
Background: A growing body of literature supports the view that people infected with HIV suffer significant pain and that 
pain is not well recognised or managed by health care professionals. This study investigated the prevalence, severity, 
recognition and management of pain in adult patients with HIV infection in a South African hospital setting.
Methods: The Brief Pain Inventory (BPI) (short form) questionnaire was administered to 100 consecutive, consenting HIV-
positive patients admitted to an urban district-level hospital in KwaZulu-Natal. Convenience sampling was employed with 
participants recruited on consecutive days. Data sources comprised patient interviews and review of hospital records. A 
Pain Management Index derived from the BPI was calculated to establish the adequacy of pain management. Descriptive 
statistics were tabulated for the recognition of pain, pain severity and appropriateness of analgesia. Correlation analyses 
were used to assess the association between pain and daily life.
Results: Ninety-one per cent of participants reported pain with 83% experiencing significant pain, in other words a “worst 
pain” rating of five or above on the BPI (short form) questionnaire. The correlation analysis between the severity of pain and 
its interference with daily life suggests that moderate and severe pain interferes with the patients’ daily functioning. Pain 
was documented on 71% of the patients’ medical charts that were reviewed; however, only 34% were considered to be 
adequately managed for their pain. 
Conclusion: Pain prevalence is high in the sample. While pain was recognised and noted in the majority of patients’ medical 
records, the management of pain was considered to be inadequate in a third of those experiencing pain. 
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Introduction
Pain in HIV-infected individuals has been recognised as a 
highly prevalent and clinically important global problem.1 
International studies dating back to 1996 have consistently 
shown that the estimates of pain prevalence in patients 
with HIV infection range from 50% to 90%.2–6 This wide 
variation may reflect differing study methodologies, differing 
populations and differing associated factors (e.g. stage 
of disease, comorbid disease and use of antiretroviral 
treatment [ART]). For example, a study conducted in New 
York in 1996 reported that 97% of patients who were 
considered to have end-stage disease had severe pain and 
that half to two-thirds of hospitalised HIV-infected patients 
suffered pain.6 A similar study conducted in Italy in 2001 
recorded a 60% pain prevalence rate amongst hospitalised 
HIV-infected patients.7
Other Western-based studies have shown that pain is 
widely prevalent regardless of the setting in which patients 
are being managed.8,9 Von Gunten estimated that at least 
one-fifth of the patients who die in hospitals each year 
experienced pain during the final admission, while a survey of 
hospice patients in nursing homes conducted by Buchanan 
et al found that about 50% had daily pain, which was severe 
in about 85% of patients.8,9 This holds true in the South 
African setting as well. For example, a study conducted in a 
hospice in Soweto showed that pain was the most common 
symptom experienced by HIV-infected patients.2 The pain 
prevalence rate in that study was 98%, with 35% of patients 
citing pain as the worst overall symptom. 
Two South African studies have recorded a pain prevalence 
of approximately 70% (71% and 69% respectively) in 
outpatients with HIV disease.10,11 Norval stated in his 
article published in 2004 that “at present HIV/AIDS-related 
literature in South Africa focuses largely on the potential 
use of antiretroviral drugs, prevention of mother-to-
child transmission, governmental policies and attitudes, 
epidemiology, vaccine trials and factors in this region causing 
such rapid spread of the virus. Textbooks and literature also 
focus on AIDS-related syndromes and tumours.”2  
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Pain in the HIV-infected individual has diverse presentations 
and is associated with significant psychological and 
functional morbidity. These patients present with unique 
and challenging symptoms in addition to various pain 
syndromes.2,12 The most frequently reported pain syndromes 
were chest pain, headache, abdominal pain, oesophageal 
and oral cavity pain, anorectal pain, pain related to 
peripheral neuropathies and musculoskeletal pain. Some 
patients suffered from more than one type of pain related to 
the HIV infection.13
Pain has also been recognised as the most common reason 
for a patient with HIV infection to be admitted to hospital; a 
large number of these patients suffer from one or more pain 
syndrome and/or more than one type of pain related to HIV 
infection.2
Pain in HIV infection has been consistently shown over the 
years to decrease the individual’s quality of life. The problem 
of pain interfering with daily living was noted in a review 
in 1996 when half of the participants complained of pain 
and over half (60%) experienced a high level of interference 
with their enjoyment of life.14 A similar finding was found in 
a multi-centre study conducted in France in 1997, where 
it was recorded  that pain severity significantly decreased 
patients’ quality of life.15 A study conducted in South Africa in 
2009 has shown that pain is one of the specific impairments 
that affect physical, psychological and social functioning in 
the HIV-infected individual’s life.10 These studies have also 
demonstrated that pain in these patients was not adequately 
treated. Further, it was noted that the more severe the 
pain, the more often doctors underestimated it. Other 
studies have shown that pain hastens death by increasing 
physiological stress, diminishing immune competence and 
decreasing the patient’s mobility.16
Given that pain in HIV infection is a common symptom, 
one would expect that pain management strategies would 
be optimum in all health care facilities, with every patient 
obtaining relief customised to his or her specific needs. 
However, very little emphasis is placed on the palliation 
of HIV/AIDS-related symptoms.1 Pain is often overlooked 
in favour of the more severe presenting complaints in 
the HIV-infected patient, for example the management of 
opportunistic infections.1 Pain management in patients with 
HIV infection presents certain unique aspects that must 
become a priority, along with treatment of the underlying 
HIV infection and the complications of immune system 
compromise. 
This study was conducted in order to determine the 
prevalence, severity, recognition and adequacy of 
pharmacological management of pain in hospitalised 
patients with HIV infection in a South African setting, and to 
make appropriate recommendations to key role players to 
develop an intervention that would optimise pain control in 
the HIV-infected patient.
Study	methodology
The study was conducted in a 142-bed, state-subsidised 
district hospital in an urban setting; the services provided 
and the demography of patients and illnesses seen are 
similar to those in other district hospitals in KwaZulu-Natal. 
The hospital has a high turnover of admissions, the majority 
of which are HIV positive and in different clinical stages of 
illness.
This descriptive analytical study was performed to assess 
whether patients had pain, how severe the pain was, 
whether health care providers asked about pain and whether 
pharmacological management of pain was adequate. 
The study did not explore the associated factors affecting 
pain or the types of pain. This is recognised as a limitation 
and further studies should review the associated factors 
affecting pain (e.g. ART, concurrent infections and type of 
pain – whether somatic, neuropathic or mixed).  
Ethics approval was obtained from the Biomedical 
Research Ethics Committee of the Nelson R Mandela 
School of Medicine and the Research Ethics Committee of 
the hospital in which the study was conducted. 
Subjects and sampling
The study population included all HIV-infected patients 
who were admitted to the medical wards during the period 
of the study. The reason for admission was not taken into 
consideration. This was a convenience sample, in other 
words a sample size chosen according to the denominator 
population, time constraints and logistics. Since this was a 
descriptive study and no statistical testing was being done in 
this study, the sample size considered only the total number 
of medical admissions with an HIV-related diagnosis in a 
three-month period. The total sample size was conveniently 
determined to be 100 (n = 100). On designated days, the 
researcher interviewed consecutive, consenting inpatients 
(numbering two to four per day) who fulfilled all the inclusion 
requirements for the study
Data collection tools
Two data collection tools were employed, namely the Brief 
Pain Inventory (BPI) (short form) questionnaire and a data 
sheet for collection of data from clinical charts.
BPI  (short form) questionnaire 
There are many validated tools to measure pain and this 
study employed the BPI (short form). The modified BPI 
(short form) has been validated in studies among cancer 
patients and in patients with non-cancer pain.17–20 This tool 
was selected as it is the shortest of the pain evaluation 
tools; it has been validated in resource-poor settings and it 
has also been used to assess pain in HIV disease.21,22
The BPI consists of a series of questions regarding pain, its 
severity and its interference with daily life. The tool uses 
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numerical rating scales (ranging from 0 to 10) to rate current 
pain and pain over the last week at its worst, lowest and average 
level. The degree of pain relief obtained from pain treatment 
is rated using a percentage scale. Pain-related interference 
with functioning (activities of daily living) is measured in 
seven domains: general activity, mood, walking, normal work, 
relations with others, sleep and enjoyment of life.18
Medical chart review data sheets 
Following the interview, every patient’s medical chart was 
retrieved and assessed for the following:
   (i) Demographic details; 
   (ii) Any documentation of pain in the history;
   (iii) Analgesics that were prescribed.
Data analysis
A simple data description was tabulated from the data 
collected on the data sheet to show the demographic 
characteristics of the participants being investigated. All 
patients who answered affirmatively to the question, “Are 
you experiencing pain of any type today?” were tabulated 
against those who answered negatively, in order to attain 
the point prevalence of pain in this group of patients. The 
severity of pain was classified using the following accepted 
scores on the BPI: mild pain = a pain score rating of 1–3, 
moderate pain = a pain score rating of 4–7 and severe pain 
= a pain score rating of 8–10.
Significant pain was determined using the BPI (short form). 
Pain rated five or above was defined as significant pain, 
because such pain has been shown to interfere significantly 
with activities of daily living.23
Adequacy of therapy was assessed using two modalities, 
namely the type of analgesic medications prescribed for 
pain and the Pain Management Index (PMI) (a measure 
derived from the BPI).
The PMI compares the potency of analgesics prescribed 
with the severity of pain intensity reported by the patient. 
For this study, the congruence between the adequacy of 
analgesic prescribed and the level of pain was determined 
by the researcher. The PMI was constructed  according to 
guidelines from numerous studies.20,24–26  To construct the 
index, the patient’s rating on the “pain at its worst” item 
of the BPI and the potency of analgesic prescribed are 
both assigned scores. Patients reporting pain intensity of 
eight or more were considered to have “severe” pain and 
coded a “3”. Patients with pain intensity between four and 
seven were rated as “moderate” and coded a “2”. Patients 
with pain intensity less than four were rated as “mild” and 
coded “1”, and patients without pain were coded “0”. Using 
a similar procedure, the potency of the analgesic received 
by each patient was classified according to the World 
Health Organization (WHO) analgesic ladder.23 Patients 
prescribed opioids conventionally used in the third step of 
the analgesic ladder for severe pain were assigned a score 
of “3”. Those prescribed opioids conventionally used in the 
second step of the analgesic ladder for moderate pain were 
assigned a score of “2”. Those receiving both a “weak” 
opioid and an adjuvant analgesic were assigned a score of 
“2”. Those receiving only non-opioid analgesics or adjuvant 
analgesics were assigned a score of “1”. If no analgesics 
were prescribed the patient was assigned a score of “0”. 
The PMI was computed by subtracting the assigned pain 
intensity score from the assigned score for prescribed 
analgesic. The index ranges from -3 (a patient with severe 
pain who is prescribed no analgesic) to +3 (a patient who 
does not report pain and is prescribed morphine). Scores 
of zero and above indicated adequate analgesic therapy 
according to WHO guidelines, whereas scores in the 
negative range indicated inadequate analgesic therapy, in 
other words patients with “severe” pain who received no 
analgesics or only non-opioid or adjuvant analgesics, or 
patients with “moderate” pain who received no analgesics 
as receiving inadequate analgesic therapy.
The effect of pain on the different parameters of daily 
life was determined from the BPI (short form). A rating of 
0–2 was scored as “no interference”. A rating of 3–7 was 
scored as “interference”. A rating of 8–10 was scored as 
“completely interferes”.
The association between pain and activities of daily living 
was determined by conducting a Pearson correlation 
coefficient analysis, where a P-value of < 0.05 was 
considered significant. 
Results
Demographic and clinical profile (Table I) 
Table I: Description of sample (n = 100)
  Male Female
    % %
Age group 21–30 years 14 20
  31–40 years 12 35
  41–50 years 7 9
  > 50 years 1 2
Employment status Employed 19 23
  Unemployed 13 37
  Disability grant 2 6
Diagnosis of HIV < 6 months 14 28
  6–12 months 6 17
  > 12 months 14 21
Stage of disease 2 1 2
  3 11 18
  4 2 2 46
CD4 group < 200 29 41
  ≥ 200 5 15
  Not recorded 9 10
ART On ART 13 21
  Not on ART 21 45
Original Research: Adequacy of pain management in HIV-positive patients Original Research: Adequacy of pain management in HIV-positive patients
74 Vol 53 No 1S Afr Fam Pract 2011
Pain prevalence, severity, documentation and 
adequacy of management
Ninety-one per cent of the patients (n = 91/100) reported 
pain, as shown in Table II. Eighty-seven per cent (n = 80/91) 
of those who reported pain described their pain as being 
significant (i.e. “worst pain” pain rating of > 5). The mean 
pain intensity “at its worst” was 8.2 (range 1–10). The mean 
pain intensity “on average” was 6.8 (range 1–10). 
A further breakdown in terms of pain severity is summarised 
in Table II.
Pain was documented on 71% of participants’ medical 
charts. The severity or intensity of pain was not recorded 
in any of the patients’ medical records. No analgesic was 
prescribed for a third (33%, n = 30/91) of the participants 
who had reported pain. Of the 67% (n = 61/91) of patients 
who were prescribed analgesics, more than half (65%, 
n = 40/61) were prescribed a non-opioid analgesic. Of those 
patients prescribed opioids (34%, n = 21/61), just under 
two-thirds (61%, n = 13/21) were prescribed weak opioids, 
conventionally used for “moderate pain”, and over two-
thirds (38%, n = 8/21) of the patients were prescribed strong 
opioids, conventionally used for “severe pain”. 
Of the subset of patients reporting “severe pain” 
(n = 60/100), only seven (11%, n = 7/60) were prescribed 
strong opioid analgesics, recommended by the WHO 
for “severe pain”. Twenty-one per cent (n = 13/60) were 
prescribed weak opioid analgesics, recommended for 
“moderate pain”. Half of the patients (51%, n = 3/60) 
who reported “severe pain” had received only non-opioid 
analgesics, and one patient with “severe pain” had received 
no analgesics. The rest of the patients in this subgroup 
(13%, n = 8/60) were prescribed adjuvant analgesics as 
their primary analgesic medication, and none of the patients 
received adjuvant analgesics in addition to an opioid.
The calculated PMI scores showed that two-thirds (66%) of 
participants had negative PMI scores, indicating inadequate 
analgesic therapy. A third (34%) had PMI scores greater than 
or equal to zero, indicating adequate analgesic therapy.
Correlation between pain and interference with daily life
The Pearson’s correlation coefficient analysis was done to 
measure the linear relationship between pain and its effect 
on daily living. The scatter block in Figure 1 indicates that 
the relationship is indeed linear with an R-square linear value 
of 0.59. The correlation coefficient calculated was 0.769, 
which indicates that there was a strong positive correlation 
between the experience of pain and its interference with 
daily life. The P-value was less than 0.001. 
Effect of pain on quality of life (Table III)
Discussion
This pilot study was conducted with the intention of 
highlighting the problem of pain amongst patients with 
HIV disease in a specific hospital setting. The study design 
Table II: Pain prevalence, severity, documentation and adequacy of 
management
Number  
(n = 100) % 
Pain prevalence









































Figure 1: Severity of pain and interference with daily life






  n % n % n %
General activity 67 7 17 18 7 73
Mood 67 4 20 20 4 67
Walking ability 22 24 60 65 9 9
Normal work 0 0 70 23 21 76
Relations with other 
people
0 0 13 85 78 14
Sleep 0 0 71 21 21 78
Enjoyment of life 0 0 71 21 21 78
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combined descriptive and analytical methodologies that 
were appropriate to give a comprehensive assessment of 
the research objectives and hypothesis. 
The sample was predominately female and it is unknown 
whether the prevalence and severity of pain in this context 
would differ between men and women in another similar 
context. The higher prevalence of women may be due to 
the higher number of women being admitted to the medical 
wards because of associated complications. It is well 
documented that the HIV/AIDS epidemic in sub-Saharan 
Africa has a distinctly gendered face; for every 10 adult men 
living with HIV, there are about 14 adult women who are HIV 
positive.27
The majority of the participants had Stage 4 disease and 
fell into the lower socioeconomic status category. This 
category of patients represents the majority of inpatients in 
the public health sector.28 Thus the findings of this study are 
relevant to the public health sector. 
It is of concern that only a minority of respondents (34%) 
were on ART on admission, while at least 67% of patients 
qualified for ART (67% had Stage 4 HIV disease and 66% 
had a CD4 count of less than 200). This is distressing given 
that ART is available free of cost at government clinics in 
South Africa. The low number of people on ART may reflect 
problems of access or of testing for HIV when the disease 
has already progressed. In South Africa, it is estimated that 
only 16% of people who require ART have access to it.29
The reported pain prevalence of 91% is exceedingly high. 
Of great concern was that, of the 91 patients who reported 
pain, 83% had significant pain and 60% reported severe 
pain. These high pain prevalence rates indicate that pain 
is an ongoing and serious problem for people with HIV 
disease. 
The review of the medical charts revealed that, even 
though pain was documented for 71% of patients, further 
assessments of pain were not done and none of the 
patients’ charts indicated the severity of pain. 
This study supports the current literature that indicates 
that pain is significantly undertreated in patients with HIV 
infection.30,31 This study also supports the view that severity 
of pain decreases the HIV-infected patient’s quality of 
life.12,14,25 The correlation analysis result between the severity 
of pain and its effect on quality of life showed a strong 
positive correlation (P-value < 0.001). This linear association 
implies that the more pain increases in severity, the more 
it affects quality of life. Although these two variables are 
positively related to each other, it cannot be concluded that 
this relationship is causal; in other words, pain does not 
necessarily cause interference with daily life. 
The study did not explore the associated factors affecting 
pain, the types of pain or the sites of pain. Other studies 
have noted that patients with AIDS can experience up to 16 
differing types and sites of pain.32
Factors such as age and stage of illness may also affect 
pain, and in this study these were not correlated with the 
prevalence and severity of pain or its effect on daily living.33 
This is recognised as a limitation and further studies should 
review the associated factors affecting pain (such as ART, 
type of pain – whether somatic, neuropathic or mixed – and 
concurrent illness, such as tuberculosis). Anti-tuberculosis 
drugs and ARVs can cause peripheral neuropathy.34
The study considered pain in isolation and considered pain 
management in terms of pharmacological management 
only. Pain should be considered in a holistic manner, as 
pain is subjective and may be influenced by many other 
factors such as mood, tiredness and anxiety. Similarly, pain 
management does not involve drug therapy only. There 
are many other adjunctive modalities available to treat 
pain successfully (e.g. physiotherapy, acupuncture and 
psychotherapy).35
These findings may not be generalised to all patients 
infected with HIV. The findings from a hospital-based 
sample may differ greatly from a population at other sites 
(e.g. clinic or community). Pain may be more prevalent in a 
hospital-based sample; however, a local community-based 
study (where home-based hospice facilities were available) 
reported a pain prevalence of 89% among participants.36 
These findings are very similar to the findings of this study.
Conclusions
Pain prevalence and severity were high, comparable to 
other studies of pain in patients with HIV infection. While the 
limitations in the measure of quality of life are recognised, the 
data show that significant pain diminishes the quality of life 
of patients with HIV disease, regardless of treatment setting. 
This study also shows that HIV-related pain was both poorly 
recognised and undermedicated, even when pain was most 
severe. The improvement of the management of pain for 
HIV-infected patients will require a comprehensive effort. 
Pain recognition and management must be prioritised. 
Validated pain assessment tools need to be incorporated 
into clinical practice. The pain assessment tools need to be 
validated in the local context as well as in local languages. 
All patients who complain of pain should be consistently 
and thoroughly evaluated with a complete history, physical 
examination and diagnostic workup. All aspects of pain 
assessment and care should be clearly documented. 
Pain management protocols and guidelines need to be 
developed and implemented. 
Barriers to adequate pain management should be explored, 
including medical personnel attitudes and practices 
of teaching pain management in undergraduate and 
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postgraduate curricula. Any system evaluation should 
also consider whether appropriate drugs are available. 
The expectations of patients in relation to management 
of their pain should be explored, particularly linked to the 
interference of pain with the tasks of daily living. 
Since pain is highly prevalent in HIV-infected patients 
according to this and other studies, it is recommended 
that future studies be expanded to include other hospitals, 
clinics and communities, to gain a better understanding of 
the prevalence, severity, recognition and management of 
pain. 
Recommendations
Pain management should be prioritised in all clinical 
facilities. Health care professionals should be trained in 
pain recognition, assessment and management. Ongoing 
clinical audits of this aspect of palliative care will improve 
the quality of life of all patients affected by HIV infection.
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